Survivor Story
Since her diagnosis with, and successful treatment for, stage 3 inflammatory breast cancer, Katrece Nolen has been a passionate advocate for other patients.
Read Katrece's Story
Since her diagnosis with, and successful treatment for, stage 3 inflammatory breast cancer, Katrece Nolen has been a passionate advocate for other patients.
Read Katrece's StoryCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 23-26; Los Angeles) brings together leading experts to accelerate progress in cancer science and medicine.
Learn More in AACR StoriesNearly 20,000 women in the United States were diagnosed with ovarian cancer last year. Read about prevention, screening, and treatment options.
Learn MoreAACR President-Elect Lillian Siu, Vinod Balachandran, John Dick, Regina Barzilay, and Scarlett Lin Gomez discuss what to expect in precision medicine, immunotherapy, hematologic malignancies, and more in 2025.
Read the AACR BlogRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreYour donation to the American Association for Cancer Research will help fund early-career investigators. Fund the future of cancer research today.
Donate NowAdvance registration is open for the AACR Annual Meeting 2025. Register by Friday, March 7, to receive discounted rates.
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
